Emerging Biopharma

Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background
Biotech

Excellergy emerges with $70M and ex-Dermavant CEO at the helm

The California biotech is developing a new drug class in hopes of redefining the standard of care for several allergic diseases.
Gabrielle Masson Oct 13, 2025 10:50am
bet poker chips

ARPA-H goes all in on in vivo cell therapy

Oct 8, 2025 4:04pm
human brain abstract art

Nilo launches with $101M and mission to harness neural circuits

Oct 8, 2025 9:55am
Aerska team

Irish biotech launches with $21M to shuttle RNAi meds to brain

Oct 1, 2025 10:34am
Fish oil pills sitting in a fish-shaped dish

Fatty acid eye injections restore vision in old mice

Sep 26, 2025 2:10pm
Gateway Lab San Diego

Eli Lilly opens latest incubator site in San Diego

Sep 26, 2025 9:55am
More News

New York Stock Exchange honors Fierce 15 winners

Sep 23, 2025 10:16am

Fierce Biotech's 2025 Fierce 15

Sep 22, 2025 8:00am

US VC launches another biotech with China-licensed asset

Sep 17, 2025 10:30am

Pfizer vet takes CEO post at new, phase 3-ready biotech

Sep 9, 2025 10:03am